3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trialCarel W. le Roux, Aila Rissanen, Barbara Zahorska‐Markiewicz et al.|The Lancet|2017Cited by 857
Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese womenMirjana Šumarac-Dumanović, Dragan Micić, Darko Stevanović et al.|International Journal of Obesity|2008Cited by 285
Dual antiglioma action of metformin: cell cycle arrest and mitochondria-dependent apoptosisAleksandra Isaković, Vladimir Trajković, D. Stevanović et al.|Cellular and Molecular Life Sciences|2007Cited by 201
In vitro and in vivo anti-melanoma action of metforminKristina Janjetović, Vladimir Trajković, Ljubica Harhaji‐Trajkovic et al.|European Journal of Pharmacology|2011Cited by 102
AMP-activated protein kinase-dependent and -independent mechanisms underlying in vitro antiglioma action of compound CLjubica Vučićević, Vladimir Trajković, Maja Misirkić et al.|Biochemical Pharmacology|2009Cited by 64